Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites

In the present study,13 bromopyrrole alkaloids, including the oroidin analogs hymenidin (2), dispacamide B (3) and dispacamide D (4), stevensine (5) and spongiacidin B (6), their derivatives lacking the imidazole ring bromoaldisin (7), longamide B (8) and longamide A (9), the dimeric oroidin derivat...

Full description

Bibliographic Details
Main Authors: Deniz Tasdemir, Michelle Tierney, Marcel Kaiser, Ernesto Fattorusso, Orazio Taglialatela-Scafati, Marialuisa Menna, Fernando Scala
Format: Article
Language:English
Published: MDPI AG 2010-07-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/8/7/2162/
_version_ 1828739918607679488
author Deniz Tasdemir
Michelle Tierney
Marcel Kaiser
Ernesto Fattorusso
Orazio Taglialatela-Scafati
Marialuisa Menna
Fernando Scala
author_facet Deniz Tasdemir
Michelle Tierney
Marcel Kaiser
Ernesto Fattorusso
Orazio Taglialatela-Scafati
Marialuisa Menna
Fernando Scala
author_sort Deniz Tasdemir
collection DOAJ
description In the present study,13 bromopyrrole alkaloids, including the oroidin analogs hymenidin (2), dispacamide B (3) and dispacamide D (4), stevensine (5) and spongiacidin B (6), their derivatives lacking the imidazole ring bromoaldisin (7), longamide B (8) and longamide A (9), the dimeric oroidin derivatives sceptrin (10) and dibromopalau’amine (11), and the non-oroidin bromopyrrolohomoarginin (12), manzacidin A (13), and agelongine (14), obtained from marine sponges belonging to Axinella and Agelas generahave been screened in vitro against four parasitic protozoa, i.e., two Trypanosoma species (T. brucei rhodesiense and T. cruzi), Leishmania donovani and Plasmodium falciparum (K1 strain, a chloroquine resistant strain), responsible of human diseases with high morbidity and, in the case of malaria, high mortality. Our results indicate longamide B (8) and dibromopalau’amine (11) to be promising trypanocidal and antileishmanial agents, while dispacamide B (3) and spongiacidin B (6) emerge as antimalarial lead compounds.In addition,evaluation of the activity of the test alkaloids (2–14) against three different enzymes (PfFabI, PfFabG, PfFabZ) involved in the de novo fatty acid biosynthesis pathway of P. falciparum (PfFAS-II) identified bromopyrrolohomoarginin (12) as a potent inhibitor of PfFabZ. The structural similarity within the series of tested molecules allowed us to draw some preliminary structure-activity relationships. Tests against the mammalian L6 cells revealed important clues on therapeutic index of the metabolites. This is the first detailed study on the antiprotozoal potential of marine bromopyrrole alkaloids.
first_indexed 2024-04-13T00:30:54Z
format Article
id doaj.art-3b9562a3e4bd4018a681eb9e088eb714
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-13T00:30:54Z
publishDate 2010-07-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-3b9562a3e4bd4018a681eb9e088eb7142022-12-22T03:10:28ZengMDPI AGMarine Drugs1660-33972010-07-01872162217410.3390/md8072162Bromopyrrole Alkaloids as Lead Compounds against Protozoan ParasitesDeniz TasdemirMichelle TierneyMarcel KaiserErnesto FattorussoOrazio Taglialatela-ScafatiMarialuisa MennaFernando ScalaIn the present study,13 bromopyrrole alkaloids, including the oroidin analogs hymenidin (2), dispacamide B (3) and dispacamide D (4), stevensine (5) and spongiacidin B (6), their derivatives lacking the imidazole ring bromoaldisin (7), longamide B (8) and longamide A (9), the dimeric oroidin derivatives sceptrin (10) and dibromopalau’amine (11), and the non-oroidin bromopyrrolohomoarginin (12), manzacidin A (13), and agelongine (14), obtained from marine sponges belonging to Axinella and Agelas generahave been screened in vitro against four parasitic protozoa, i.e., two Trypanosoma species (T. brucei rhodesiense and T. cruzi), Leishmania donovani and Plasmodium falciparum (K1 strain, a chloroquine resistant strain), responsible of human diseases with high morbidity and, in the case of malaria, high mortality. Our results indicate longamide B (8) and dibromopalau’amine (11) to be promising trypanocidal and antileishmanial agents, while dispacamide B (3) and spongiacidin B (6) emerge as antimalarial lead compounds.In addition,evaluation of the activity of the test alkaloids (2–14) against three different enzymes (PfFabI, PfFabG, PfFabZ) involved in the de novo fatty acid biosynthesis pathway of P. falciparum (PfFAS-II) identified bromopyrrolohomoarginin (12) as a potent inhibitor of PfFabZ. The structural similarity within the series of tested molecules allowed us to draw some preliminary structure-activity relationships. Tests against the mammalian L6 cells revealed important clues on therapeutic index of the metabolites. This is the first detailed study on the antiprotozoal potential of marine bromopyrrole alkaloids.http://www.mdpi.com/1660-3397/8/7/2162/bromopyrrole alkaloidsantiprotozoal activityenzyme inhibitionTrypanosomaLeishmaniaPlasmodium
spellingShingle Deniz Tasdemir
Michelle Tierney
Marcel Kaiser
Ernesto Fattorusso
Orazio Taglialatela-Scafati
Marialuisa Menna
Fernando Scala
Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
Marine Drugs
bromopyrrole alkaloids
antiprotozoal activity
enzyme inhibition
Trypanosoma
Leishmania
Plasmodium
title Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
title_full Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
title_fullStr Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
title_full_unstemmed Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
title_short Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
title_sort bromopyrrole alkaloids as lead compounds against protozoan parasites
topic bromopyrrole alkaloids
antiprotozoal activity
enzyme inhibition
Trypanosoma
Leishmania
Plasmodium
url http://www.mdpi.com/1660-3397/8/7/2162/
work_keys_str_mv AT deniztasdemir bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT michelletierney bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT marcelkaiser bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT ernestofattorusso bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT oraziotaglialatelascafati bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT marialuisamenna bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites
AT fernandoscala bromopyrrolealkaloidsasleadcompoundsagainstprotozoanparasites